A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
A paper by a team of faculty members from the Jacobs School of Medicine and Biomedical Sciences and Roswell Park Comprehensive Cancer Center has been selected amongst the “Top 10 Cited Papers” of the journal Microorganisms in 2023.
Data-driven long COVID definition will help support public health initiatives while providing clinicians with a more nuanced basis for screening and diagnosis.
Thirty-five doctoral, 76 master’s and 209 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.
New findings by UB researchers reveal that RNA editing may play a larger role in human biology and in the development of human disease than has generally been understood.
Sabrina Orsi, a student in the doctoral program in pharmacology and toxicology, won the People’s Choice Award at UB’s eighth annual Three Minute Thesis (3MT) competition.
Peter L. Elkin, MD, professor and chair of biomedical informatics, has been elected to the board of directors of the Association for Clinical and Translational Science (ACTS).
